droplet digital PCR Bio-Rad Laboratories, Stilla Technologies Settle IP Lawsuit Bio-Rad had alleged Stilla's Naica digital PCR system infringed on four patents held or licensed by the firm. SARS-CoV-2 Study Implicates Saliva in Viral Transmission Viral entry factors were broadly enriched in the salivary glands and oral mucosae, implicating the oral cavity as an important infection site. Circulating Tumor DNA Provides Prognostic Clues in Advanced BRAF-Mutated Melanoma Cases Using the BRAF-V600 tumor mutation as a marker, investigators identified pre-treatment and on-treatment ties between ctDNA and patient outcomes. Bio-Rad Q3 Revenues Jump 15 Percent Bio-Rad's year-over-year Q3 revenue increase was driven primary by sales of PCR and Droplet Digital PCR products due to the COVID-19 pandemic. Biodesix Prices $72M IPO Shares of the Boulder, Colorado-based firm will begin trading on the Nasdaq today under ticker symbol "BDSX" at $18 per share. Sep 8, 2020 UCLA 'Click Chip’ Detects Early-Stage Liver Cancer Biomarkers in Extracellular Vesicles Premium Jul 30, 2020 Bio-Rad Q2 Revenues Fall 6 Percent on COVID-19 Impact May 4, 2020 Bio-Rad Laboratories Gets FDA Emergency Use Authorization for ddPCR COVID-19 Assay Apr 16, 2020 Multi-Analyte Liquid Biopsy Panel May Aid in Pancreatic Cancer Detection, Staging Premium Mar 29, 2020 Bio-Rad Laboratories ddPCR Shows Accuracy Benefits in COVID-19 Detection Studies Feb 10, 2020 Fetal Cell-Based NIPT by Droplet Digital PCR Demonstrated in Japanese Pilot Study Premium Jan 21, 2020 FNIH Team Selects Cancer Biomarkers in Phase I of Liquid Biopsy Reference Standards Project Premium Jan 13, 2020 JP Morgan Healthcare Day One: Qiagen, Guardant Health, Bio-Rad, Hologic, Myriad Genetics Oct 31, 2019 Bio-Rad's Q3 Revenues Increase 3 Percent, Beat Analysts' Estimate Aug 1, 2019 Bio-Rad Q2 Revenues Down 1 Percent May 8, 2019 Bio-Rad Laboratories Reports Flat Q1 Revenues Mar 5, 2019 Lung Cancer Diagnostic Approach Takes Aim at Identifying Malignancy, Guiding Immunotherapy From Single Sample Premium Feb 28, 2019 Bio-Rad Q4 Revenues Down 1 Percent, Beat Estimates Feb 22, 2019 Bio-Rad Expects Expansion of Clinical ddPCR System Menu With FDA Clearance Premium Feb 15, 2019 Bio-Rad Clinical ddPCR Test, Diagnostic System Get FDA Clearance Nov 1, 2018 Roche Developing Digital PCR Platform Premium Oct 25, 2018 Liquid Biopsy of HPV DNA Shows Promise for Monitoring Remission in Oral Cancer Premium Oct 15, 2018 Liquid Biopsy Shows Promise for Monitoring Childhood Brain Tumors Sep 4, 2018 True Bearing Readies RNA-Based Coronary Artery Disease Diagnostic for FDA Review, Launch Premium Aug 7, 2018 Bio-Rad Q2 Revenues Jump 14 Percent Load More Breaking News Epic Sciences, Biosplice Therapeutics Partner on Multiomic Profiling for Cancer Trials Hamilton, Pacific Biosciences Partner on Automating DNA Sample Prep Danaher Q4 Revenues Rise 21 Percent COVID-19 Severity Biomarker Candidates Revealed in RNA Sequencing Study Flatiron Health, Japanese Hospital Partner on Real-World GI Cancer Database Abbott Q4 Diagnostics Revenues Grow 3 Percent, Full-Year Revenues up 25 Percent The Scan Polarized Science Confidence A new survey finds that confidence in science among US adults is increasingly polarized, the Associated Press says. Time to Sit Back and Relax NPR reports that the US National Institutes of Health has transferred the last of its eligible former research chimpanzees to a sanctuary. Omicron-Focused Vaccines The New York Times reports both Pfizer-BioNTech and Moderna have launched trials of SARS-CoV-2 vaccines targeting the Omicron variant. Nature Papers Present Cloud-Computing Analysis Approach, Transcription Factor With Role in Bacterial Genome Organization In Nature this week: researchers describe the free, open-source cloud-computing infrastructure Serratus and more.